Epigenic Therapeutics Revenue

Biotechnology Research • Pudong, Shanghai, China • 11-20 Employees

Epigenic Therapeutics revenue & valuation

Annual revenue	$3,000,000
Revenue per employee	$215,000
Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues	$9,600,000
Total funding	$102,000,000

Key Contacts at Epigenic Therapeutics

Bob Zhang

Ceo, Co-Founder

Minghao Bao

Head Of Hr & Government Affairs, Sr. Director

Yuruo Xie

Founders Executive Assistant

Company overview

Headquarters	上海浦东新区上海自贸壹号生命科技产业园(一期)4-15F6F, 上海, 上海, CN
Website	epigenictx.com
NAICS	541714
Keywords	Gene Therapy And Epigenetic Editing
Founded	2021
Employees	11-20
Socials

Epigenic Therapeutics Email Formats

Epigenic Therapeutics uses 2 email formats. The most common is {first initial}.{last name} (e.g., j.doe@epigenictx.com), used 71.4% of the time.

Format	Example	Percentage
{first initial}.{last name}	j.doe@epigenictx.com	71.4%
{first name}.{last name}	john.doe@epigenictx.com	28.6%

About Epigenic Therapeutics

Epigenic Therapeutics is a frontier biotechnology company dedicated to developing next generation gene editing therapy utilizing regulation of epigenetic genome for a variety of diseases. Founded in 2021 by leading scientists focused on discovering gene editing technologies and developing gene editing therapies, the company has multiple product candidates in the pipeline, including treatment for metabolic, cardiovascular, viral hepatitis, ocular and rare diseases.

Employees by Management Level

Total employees: 11-20

Seniority

Employees

Entry

Head

C-Suite

Employees by Department

Epigenic Therapeutics has 5 employees across 4 departments.

Departments

Number of employees

Funding Data

Explore Epigenic Therapeutics's funding history, including investment rounds, total capital raised, and key backers.

Funding Date	Round	Amount
2023-09-29	4	$32,000,000
2024-10-09	4	$10,000,000
2025-10-07	5	$60,000,000

Funding Insights

$102,000,000

Total funding amount

$60,000,000

Most recent funding amount

Number of funding rounds

Epigenic Therapeutics Tech Stack

Discover the technologies and tools that power Epigenic Therapeutics's digital infrastructure, from frameworks to analytics platforms.

Baidu Analytics

Analytics

jQuery

JavaScript libraries

Nginx

Reverse proxies

PHP

Programming languages

HSTS

Security

Sectigo

SSL/TLS certificate authorities

Swiper

JavaScript libraries

Lenis

JavaScript libraries

Frequently asked questions

Epigenic Therapeutics is located in Pudong, Shanghai, CN.

Epigenic Therapeutics generates an estimated annual revenue of $3,000,000. This revenue figure reflects the company's market position and business performance in its industry.

Epigenic Therapeutics has an estimated valuation of $9,600,000. This valuation is calculated based on industry-standard revenue multiples and reflects the company's growth potential and market positioning.

Epigenic Therapeutics was founded in 2021, making it 5 years old. The company has established itself as a significant player in its industry over this time.

Epigenic Therapeutics has approximately 11-20 employees. The company continues to grow its workforce to support its business operations and expansion.

Epigenic Therapeutics has raised a total of $102,000,000 across 3 funding rounds. This investment has helped the company grow and expand its operations.

Key Contacts at Epigenic Therapeutics

Bob Zhang

Ceo, Co-Founder

Minghao Bao

Head Of Hr & Government Affairs, Sr. Director

Yuruo Xie

Founders Executive Assistant

4.8

40,000 users